BiomX Stock Gains From Favorable Study Data Presentation on BX004 [Yahoo! Finance]
BiomX Inc. COmmon Stock (PHGE)
Company Research
Source: Yahoo! Finance
BX004 is used for treating cystic fibrosis (CF) patients with chronic pulmonary infections caused by Pseudomonas aeruginosa (PsA). BiomX will present this study data at the North American Cystic Fibrosis Conference in Boston. PHGE Stock's Likely Trend Following the News Shares of PHGE rose 2.8% to $1.05 yesterday following the news. To date, BX004 has been under several trials. It has shown exceptionally positive results in treating patients with CF. The company has already received the FDA's Fast Track and Orphan Drug Designation for BX004 which has significantly boosted investors' sentiment. Given the latest favorable trial data, we expect market sentiment toward PHGE stock to remain positive. Meanwhile, PHGE currently has a market capitalization of $18.9 million. In the last reported quarter, it delivered an earnings surprise of 158.33%. More on BiomX's Phase 1b/2a Study The trial took place in two parts. In part one, the BX004-A cocktail showed a greater reduction in P
Show less
Read more
Impact Snapshot
Event Time:
PHGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PHGE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PHGE alerts
High impacting BiomX Inc. COmmon Stock news events
Weekly update
A roundup of the hottest topics
PHGE
News
- BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis ConferenceGlobeNewswire
- BiomX to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceGlobeNewswire
- BiomX to Present Positive Phase 1b/2a Clinical Trial Data for BX004 at the European Respiratory Society (ERS) Congress 2024GlobeNewswire
- UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock SplitGlobeNewswire
- BiomX Inc. (PHGE) Q2 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
PHGE
Earnings
- 8/15/24 - Beat
PHGE
Sec Filings
- 9/26/24 - Form 8-K
- 9/18/24 - Form 4
- 9/18/24 - Form 4
- PHGE's page on the SEC website